Skip to main content
Clinical Trials/NCT03186066
NCT03186066
Completed
Not Applicable

A Prospective Randomized Controlled Multicenter Trial for Evaluation of the Flamingo Device in Endoscopic Treatment of the Buried Bumper Syndrome.

Kliniken Ludwigsburg-Bietigheim gGmbH1 site in 1 country52 target enrollmentJune 2, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Buried Bumper Syndrome
Sponsor
Kliniken Ludwigsburg-Bietigheim gGmbH
Enrollment
52
Locations
1
Primary Endpoint
Time for Removal of PEG
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Percutaneous endoscopic gastrostomy (PEG) is a method for nutrition delivery for patients with insufficient oral intake. A rare but severe complication of PEG is the Buried Bumper Syndrome (BBS). In BBS the internal fixation device of the PEG migrates along the stoma chanel. The internal fixation disc becomes covered by gastric mucosa, which causes loss of patency, fixation of the PEG and possible leakage around the PEG.

BBS can be treated endoscopically by dissecting the overgrowing tissue with endoscopic submucosal dissection (ESD) knifes. A new and alternative approach is the use of the Flamingo device, which is inserted over the PEG and then is used to radially dissect the overgrowing tissue with a cutting wire.

In this study both methods, the standard method using an ESD knife and the Flamingo device, are compared in a randomized controlled open-label trial. Primary endpoint is the time needed for PEG removal.

Registry
clinicaltrials.gov
Start Date
June 2, 2017
End Date
April 8, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Kliniken Ludwigsburg-Bietigheim gGmbH
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Endoscopy proven Buried Bumper Syndrome
  • PEG or Jet-PEG

Exclusion Criteria

  • Major Coagulation disorder
  • Percutaneous endoscopic jejunostomy or use of a ballon fixed device

Outcomes

Primary Outcomes

Time for Removal of PEG

Time Frame: Assessed at day 1 (day of intervention)

Secondary Outcomes

  • Success rate(Assessed at day 1)
  • Complications(Assessed during follow-up for up to ten days)

Study Sites (1)

Loading locations...

Similar Trials